| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.75B | +3.9% |
| Gross profit | ¥0.26B | — |
| Operating income | ¥0.08B | — |
| Net income | ¥0.06B | +62.6% |
| Gross margin | 34.6% | Net margin 7.9% |
| Revenue Q/Q | -6.8% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.49B | 65.4% |
| R&D | ¥0.04B | 5.1% |
| SG&A | ¥0.13B | 17.5% |
| Tax & other | ¥0.02B | 2.4% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
开尔新材 ・ 方直科技 ・ 上海新阳 ・ ST美晨 ・ 冠昊生物 ・ 东宝生物 ・ 飞力达 ・ 瑞丰光电 ・ 佳云科技 ・ 瑞丰高材 ・ 迪安诊断 ・ ST天玑
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies